Innovations_in_Molecular_Mechanisms_and_Tissue_Engineering_(Stem_Cell_Biology_and_Regenerative_Medicine)

(Brent) #1

168



  1. Bydon M, Lin J, Macki M et al (2014) The current role of steroids in acute spinal cord injury.
    World Neurosurg 82:848–854. doi: 10.1016/j.wneu.2013.02.062

  2. Kim Y, Caldwell J-M, Bellamkonda RV (2009) Nanoparticle-mediated local delivery of
    Methylprednisolone after spinal cord injury. Biomaterials 30:2582–2590. doi: 10.1016/j.
    biomaterials.2008.12.077

  3. Cerqueira SR, Oliveira JM, Silva NA et al (2013) Microglia response and in vivo therapeutic
    potential of methylprednisolone-loaded dendrimer nanoparticles in spinal cord injury. Small
    9:738–749. doi: 10.1002/smll.201201888

  4. Jain NK, Mishra V, Mehra NK (2013) Targeted drug delivery to macrophages. Expert Opin
    Drug Deliv 10:353–367. doi: 10.1517/17425247.2013.751370

  5. Hu W, Metselaar J, Ben L-H et al (2009) PEG minocycline-liposomes ameliorate CNS auto-
    immune disease. PLoS One 4, e4151. doi: 10.1371/journal.pone.0004151

  6. Wang Y-C, Wu Y-T, Huang H-Y et al (2008) Sustained intraspinal delivery of neurotrophic
    factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury.
    Biomaterials 29:4546–4553. doi: 10.1016/j.biomaterials.2008.07.050

  7. Lu K-W, Chen Z-Y, Jin D-D et al (2002) Cationic liposome-mediated GDNF gene transfer
    after spinal cord injury. J Neurotrauma 19:1081–1090. doi: 10.1089/089771502760341983

  8. Hedley ML, Curley J, Urban R (1998) Microspheres containing plasmid-encoded antigens
    elicit cytotoxic T-cell responses. Nat Med 4:365–368. doi: 10.1038/nm0398-365

  9. Kim D, Schallert T, Browarak T et al (2001) Transplantation of Genetically Modifi ed Fibroblasts
    Expressing BDNF in Adult Rats with a Subtotal Hemisection Improves Specifi c Motor and
    Sensory Functions. Neurorehabil Neural Repair 15:141–150. doi: 10.1177/154596830101500207

  10. Langer R (1990) New methods of drug delivery. Science (80- ) 249:1527–1533.

  11. Nie L, Zhang G, Hou R et al (2015) Controllable promotion of chondrocyte adhesion and
    growth on PVA hydrogels by controlled release of TGF-β1 from porous PLGA microspheres.
    Colloids Surf B Biointerfaces 125:51–57. doi: 10.1016/j.colsurfb.2014.11.010

  12. Cao X, Shoichet MS (1999) Delivering neuroactive molecules from biodegradable micro-
    spheres for application in central nervous system disorders. Biomaterials 20:329–339.
    doi: 10.1016/S0142-9612(98)00172-0

  13. Benoit J-P, Faisant N, Venier-Julienne M-C, Menei P (2000) Development of microspheres
    for neurological disorders: from basics to clinical applications. J Control Release 65:285–

  14. doi: 10.1016/S0168-3659(99)00250-3

  15. Burdick JA, Ward M, Liang E et al (2006) Stimulation of neurite outgrowth by neurotrophins
    delivered from degradable hydrogels. Biomaterials 27:452–459. doi: 10.1016/j.biomaterials.
    2005.06.034

  16. Kim H, Zahir T, Tator CH, Shoichet MS (2011) Effects of dibutyryl cyclic-AMP on survival
    and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord
    injured rats. PLoS One 6, e21744. doi: 10.1371/journal.pone.0021744

  17. Ashton RS, Banerjee A, Punyani S et al (2007) Scaffolds based on degradable alginate hydro-
    gels and poly(lactide-co-glycolide) microspheres for stem cell culture. Biomaterials 28:5518–

  18. doi: 10.1016/j.biomaterials.2007.08.038

  19. Prang P, Müller R, Eljaouhari A et al (2006) The promotion of oriented axonal regrowth in
    the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials
    27:3560–3569. doi: 10.1016/j.biomaterials.2006.01.053

  20. Read T-A, Stensvaag V, Vindenes H et al (1999) Cells encapsulated in alginate: a potential
    system for delivery of recombinant proteins to malignant brain tumours. Int J Dev Neurosci
    17:653–663. doi: 10.1016/S0736-5748(99)00052-0

  21. Tobias CA, Han SSW, Shumsky JS et al (2005) Alginate encapsulated BDNF-producing
    fi broblast grafts permit recovery of function after spinal cord injury in the absence of immune
    suppression. 22:138–156

  22. Pêgo AP, Kubinova S, Cizkova D et al (2012) Regenerative medicine for the treatment of
    spinal cord injury: more than just promises? J Cell Mol Med 16:2564–2582.
    doi: 10.1111/j.1582-4934.2012.01603.x

  23. Gennai S, Monsel A, Hao Q et al (2015) Cell-based therapy for traumatic brain injury. Br
    J Anaesth 115:203–212. doi: 10.1093/bja/aev229


A. Roussas et al.
Free download pdf